Ebru Başaran

675 total citations
27 papers, 541 citations indexed

About

Ebru Başaran is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Ebru Başaran has authored 27 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmaceutical Science, 5 papers in Molecular Biology and 5 papers in Biomaterials. Recurrent topics in Ebru Başaran's work include Advanced Drug Delivery Systems (15 papers), Advancements in Transdermal Drug Delivery (11 papers) and Ocular Surface and Contact Lens (5 papers). Ebru Başaran is often cited by papers focused on Advanced Drug Delivery Systems (15 papers), Advancements in Transdermal Drug Delivery (11 papers) and Ocular Surface and Contact Lens (5 papers). Ebru Başaran collaborates with scholars based in Türkiye, Czechia and Yemen. Ebru Başaran's co-authors include Yasemin Yazan, Müzeyyen Demirel, Evrim Yenilmez, Behiye Şenel, Gülay Büyükköroğlu, Başar Sırmagül, A. Alper Öztürk, Şenay Sarıca, Naile Öztürk and Rana Arslan and has published in prestigious journals such as Carbohydrate Polymers, International Journal of Pharmaceutics and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Ebru Başaran

25 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ebru Başaran Türkiye 13 322 130 125 120 62 27 541
Rathapon Asasutjarit Thailand 15 364 1.1× 129 1.0× 114 0.9× 154 1.3× 89 1.4× 31 712
Guadalupe Abrego Spain 13 381 1.2× 135 1.0× 89 0.7× 182 1.5× 86 1.4× 14 653
Helen L. Alvarado Spain 13 379 1.2× 131 1.0× 90 0.7× 191 1.6× 102 1.6× 16 688
Giulia Di Prima Italy 14 214 0.7× 112 0.9× 87 0.7× 110 0.9× 32 0.5× 29 478
Swarnali Das Paul India 12 299 0.9× 99 0.8× 117 0.9× 96 0.8× 57 0.9× 35 527
Junfeng Ban China 13 267 0.8× 141 1.1× 87 0.7× 101 0.8× 40 0.6× 28 501
Viliana Gugleva Bulgaria 11 196 0.6× 62 0.5× 57 0.5× 90 0.8× 48 0.8× 22 384
Marcelle Silva-Abreu Spain 13 301 0.9× 83 0.6× 104 0.8× 112 0.9× 50 0.8× 26 597
Saadia A. Tayel Egypt 14 638 2.0× 156 1.2× 72 0.6× 125 1.0× 88 1.4× 18 860
Dalia Ghorab Egypt 15 319 1.0× 94 0.7× 90 0.7× 91 0.8× 29 0.5× 20 517

Countries citing papers authored by Ebru Başaran

Since Specialization
Citations

This map shows the geographic impact of Ebru Başaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebru Başaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebru Başaran more than expected).

Fields of papers citing papers by Ebru Başaran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebru Başaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebru Başaran. The network helps show where Ebru Başaran may publish in the future.

Co-authorship network of co-authors of Ebru Başaran

This figure shows the co-authorship network connecting the top 25 collaborators of Ebru Başaran. A scholar is included among the top collaborators of Ebru Başaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebru Başaran. Ebru Başaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Şenel, Behiye, et al.. (2024). Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy. ACS Omega. 9(10). 11671–11685. 5 indexed citations
3.
Öztürk, A. Alper, Ebru Başaran, Behiye Şenel, Müzeyyen Demirel, & Şenay Sarıca. (2023). Synthesis, characterization, antioxidant activity of Quercetin, Rutin and Quercetin-Rutin incorporated β-cyclodextrin inclusion complexes and determination of their activity in NIH-3T3, MDA-MB-231 and A549 cell lines. Journal of Molecular Structure. 1282. 135169–135169. 12 indexed citations
4.
5.
Yenilmez, Evrim, A. Alper Öztürk, & Ebru Başaran. (2023). Preparation and In vitro, Ex vivo Evaluation of Benzidamine HydrochlorideLoaded Fast Dissolving Oral Strip Formulations: Treatment of OralMucositis Due to Side Effects of Chemotherapy and Radiotherapy. Letters in Drug Design & Discovery. 20(8). 1147–1157. 3 indexed citations
6.
Başaran, Ebru, et al.. (2022). Formulation and characterization studies of inclusion complexes of voriconazole for possible ocular application. Pharmaceutical Development and Technology. 27(2). 228–241. 5 indexed citations
7.
Başaran, Ebru, A. Alper Öztürk, Behiye Şenel, Müzeyyen Demirel, & Şenay Sarıca. (2022). Quercetin, Rutin And Quercetin-Rutin Incorporated Hydroxypropyl β-Cyclodextrin Inclusion Complexes. European Journal of Pharmaceutical Sciences. 172. 106153–106153. 52 indexed citations
8.
Başaran, Ebru, et al.. (2020). Preparation and in vitro characterization of rosuvastatin calcium incorporated methyl beta cyclodextrin and Captisol® inclusion complexes. Drug Development and Industrial Pharmacy. 46(9). 1495–1506. 19 indexed citations
9.
Başaran, Ebru, et al.. (2020). Physicochemical characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated solid lipid nanoparticles. International Journal of Pharmaceutics. 578. 119106–119106. 27 indexed citations
10.
Başaran, Ebru. (2017). Ocular Application of Dirithromycin Incorporated Polymeric Nanoparticles: an <i>In Vitro</i> Evaluation. Turkish Journal of Pharmaceutical Sciences. 14(2). 191–200. 11 indexed citations
11.
Yenilmez, Evrim, et al.. (2017). Preparation, Characterization and In Vitro Evaluation of Dirithromycin Loaded Eudragit (R) RS 100 Nanoparticles for Topical Application. 1 indexed citations
12.
Başaran, Ebru, et al.. (2017). Voriconazole Incorporated Polymeric Nanoparticles for Ocular Application. 6 indexed citations
13.
Büyükköroğlu, Gülay, Behiye Şenel, Ebru Başaran, Evrim Yenilmez, & Yasemin Yazan. (2016). Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer. European Journal of Pharmaceutics and Biopharmaceutics. 109. 174–183. 51 indexed citations
14.
Büyükköroğlu, Gülay, et al.. (2016). Development of paclitaxel-loaded liposomal systems with anti-her2 antibody for targeted therapy. Tropical Journal of Pharmaceutical Research. 15(5). 895–895. 5 indexed citations
15.
Başaran, Ebru, et al.. (2015). Ornidazole Incorporated Chitosan Nanoparticles for Ocular Application. 12 indexed citations
16.
Başaran, Ebru, et al.. (2013). Chitosan nanoparticles for ocular delivery of cyclosporine A. Journal of Microencapsulation. 31(1). 49–57. 65 indexed citations
17.
Başaran, Ebru & Yasemin Yazan. (2012). Ocular application of chitosan. Expert Opinion on Drug Delivery. 9(6). 701–712. 59 indexed citations
18.
Başaran, Ebru, Müzeyyen Demirel, Başar Sırmagül, & Yasemin Yazan. (2011). Polymeric Cyclosporine-A Nanoparticles for Ocular Application. Journal of Biomedical Nanotechnology. 7(5). 714–723. 13 indexed citations
19.
Başaran, Ebru, Müzeyyen Demirel, Başar Sırmagül, & Yasemin Yazan. (2010). Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. Journal of Microencapsulation. 27(1). 37–47. 84 indexed citations
20.
Başaran, Ebru, et al.. (2010). Release characteristics of vitamin E incorporated chitosan microspheres and in vitro–in vivo evaluation for topical application. Carbohydrate Polymers. 84(2). 807–811. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rathapon Asasutjarit Breakdown of academic impact, for papers by Guadalupe Abrego Breakdown of academic impact, for papers by Helen L. Alvarado Breakdown of academic impact, for papers by Giulia Di Prima Breakdown of academic impact, for papers by Swarnali Das Paul Breakdown of academic impact, for papers by Junfeng Ban Breakdown of academic impact, for papers by Viliana Gugleva Breakdown of academic impact, for papers by Marcelle Silva-Abreu Breakdown of academic impact, for papers by Saadia A. Tayel Breakdown of academic impact, for papers by Dalia Ghorab
Rankless by CCL
2026